InVenis Biotherapies
Entity

  • InVenis Biotherapies

    Created in 2021
  • BETA

    To investigate (B)
    Some signals may appear as inconsistent with a regular activity

  • Social networks

    189

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Parc Eurasanté Ouest, 70 Rue du Dr Yersin, 59120 Loos, France

    Loos

    France

  • Employees

    Scale: 2-10

    Estimated: 2

  • Engaged corporates

    7
    5 1

  • Added in Motherbase

    1 year, 4 months ago
Description
  • Value proposition

    Platelet-derived Regenerative Therapy for CNS Disorders

    InVenis Biotherapies is a biotech compagny, spin-off from academic laboratory U1172 and Taipei Medical University, developping innovative regenerative therapies based on blood platelet. Thanks to the high therapeutic potential of our product, we target the most severe diseases involving cell death, as the amyotrophic lateral sclerosis.

Corporate interactions BETA
Corporate TypeTweets Articles
OBRATORI
OBRATORI
Venture Capital and Private Equity Principals
OBRATORI
Venture Capital and Private Equity Principals 		Other

21 Oct 2024


Réseau SATT
Réseau SATT
Réseau SATT
Other

7 Oct 2024


SATT CONECTUS
SATT CONECTUS
Research, Research Services
SATT CONECTUS
Research, Research Services 		Other

26 Sep 2024


France Biotech
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research 		Other

18 Jan 2024


SATT Nord
SATT Nord
SATT Nord
Other

6 Aug 2024


Eurasanté
Eurasanté
Startup accelerator & VC, Biotechnology, Biotechnology Research
Eurasanté
Startup accelerator & VC, Biotechnology, Biotechnology Research 		Other

14 Dec 2023


CIC
CIC
Bank, Banking
CIC
Bank, Banking 		Other

30 Nov 2022


Similar entities
Last news
Show all articles
Social network dynamics